Table 1: Basal characteristics of the 163 patients with COPD treated in the pulmonary Rehabilitation Program.
Variables | n(%) | M ± SD |
---|---|---|
Sample | 163 (100) | |
Male | 105 (64.4) | |
Female | 58 (35.6) | |
COPD | ||
Mild | 9 (5.5) | |
Moderate | 53 (32.5) | |
Severe | 58 (35.6) | |
Very severe | 43 (26.4) | |
Lung function | ||
FVCL | 2.31 ± 0.93 | |
FVC % foreseen | 65.39 ± 21.84 | |
FEV1 L | 1.19 ± 0.58 | |
FEV1 % foreseen | 42.82 ± 17.96 | |
FEV1/FVC | 53.79 ± 17.02 | |
6MWT | ||
Before | 405.08 ± 99.41 | |
After | 459.92 ± 99.24* | |
BDI | ||
Before | 11.25 ± 7.98 | |
After | 8.23 ± 6.81* | |
BAI | ||
Before | 9.86 ± 6.55 | |
After | 7.53 ± 7.24* |
*Significance of p < 0.001 for before and after the 12-week Pulmonary Rehabilitation Program.
Anxiety and depression had a significant reduction of their levels (9.86 ± 6.55 vs. 7.53 ± 7.24*; 11.25 ± 7.98 vs. 8.23 ± 6.81*, respectively) when compared to before and after PRP. Another variable that had a significant improvement was the functional performance, which can be evaluated by the increase of distance traveled in the 6MWT (405.08 ± 99.41 vs. 459.92 ± 99.24*).